Literature DB >> 21703172

Who pulls the trigger: JNK activation in liver lipotoxicity?

Samar H Ibrahim, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21703172      PMCID： PMC3297468          DOI： 10.1016/j.jhep.2011.04.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  20 in total

1.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

Authors:  F Urano; X Wang; A Bertolotti; Y Zhang; P Chung; H P Harding; D Ron
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

2.  Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax.

Authors:  Yan Wang; Lynne M Ausman; Robert M Russell; Andrew S Greenberg; Xiang-Dong Wang
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

3.  Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.

Authors:  Yuko Akazawa; Sophie Cazanave; Justin L Mott; Nafisa Elmi; Steven F Bronk; Shigeru Kohno; Michael R Charlton; Gregory J Gores
Journal:  J Hepatol       Date:  2010-02-13       Impact factor: 25.083

Review 4.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress.

Authors:  Ira Tabas; David Ron
Journal:  Nat Cell Biol       Date:  2011-03       Impact factor: 28.824

5.  Stress signaling in the methionine-choline-deficient model of murine fatty liver disease.

Authors:  Russell K Soon; Jim S Yan; James P Grenert; Jacquelyn J Maher
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

6.  Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.

Authors:  Takahisa Nakamura; Masato Furuhashi; Ping Li; Haiming Cao; Gurol Tuncman; Nahum Sonenberg; Cem Z Gorgun; Gökhan S Hotamisligil
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

7.  Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.

Authors:  Samar H Ibrahim; Yuko Akazawa; Sophie C Cazanave; Steven F Bronk; Nafisa A Elmi; Nathan W Werneburg; Daniel D Billadeau; Gregory J Gores
Journal:  J Hepatol       Date:  2010-11-23       Impact factor: 25.083

8.  Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells.

Authors:  Yuren Wei; Dong Wang; Christopher L Gentile; Michael J Pagliassotti
Journal:  Mol Cell Biochem       Date:  2009-05-15       Impact factor: 3.396

9.  JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Justin L Mott; Nafisa A Elmi; Steven F Bronk; Nathan W Werneburg; Yuko Akazawa; Alisan Kahraman; Sean P Garrison; Gerard P Zambetti; Michael R Charlton; Gregory J Gores
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

10.  Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Faridoddin Mirshahi; Onpan Cheung; Ramesh Natarajan; James W Maher; John M Kellum; Arun J Sanyal
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682
View more
  11 in total

1.  Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.

Authors:  Sanda Win; Tin Aung Than; Bao Han Allison Le; Carmen García-Ruiz; Jose C Fernandez-Checa; Neil Kaplowitz
Journal:  J Hepatol       Date:  2015-02-07       Impact factor: 25.083

2.  Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction.

Authors:  Yuwei Jiang; Jiaoya Xu; Ping Huang; Lili Yang; Yang Liu; Yiping Li; Jue Wang; Haiyan Song; Peiyong Zheng
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

Review 3.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Liver Int       Date:  2014-09       Impact factor: 5.828

5.  c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src.

Authors:  Sanda Win; Tin Aung Than; Robert Win Maw Min; Mariam Aghajan; Neil Kaplowitz
Journal:  Hepatology       Date:  2016-03-15       Impact factor: 17.425

6.  Liver Injury and the Activation of the Hepatic Myofibroblasts.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Curr Pathobiol Rep       Date:  2013-09-01

7.  NR4A1 enhances MKP7 expression to diminish JNK activation induced by ROS or ER-stress in pancreatic β cells for surviving.

Authors:  Ze-Qing Pu; Tian-Fu Yu; Dong Liu; Cheng-Wen Jin; Esha Sadiq; Xiaofei Qiao; Xiaojie Li; Yuxuan Chen; Jinsong Zhang; Mingzhong Tian; Siying Li; Ru-Xing Zhao; Xiang-Dong Wang
Journal:  Cell Death Discov       Date:  2021-06-04

8.  Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress.

Authors:  Dandan Zhong; Hongkai Wang; Ming Liu; Xuechen Li; Ming Huang; Hong Zhou; Shuqian Lin; Zhibin Lin; Baoxue Yang
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

9.  Estradiol Uses Different Mechanisms in Astrocytes from the Hippocampus of Male and Female Rats to Protect against Damage Induced by Palmitic Acid.

Authors:  Laura M Frago; Sandra Canelles; Alejandra Freire-Regatillo; Pilar Argente-Arizón; Vicente Barrios; Jesús Argente; Luis M Garcia-Segura; Julie A Chowen
Journal:  Front Mol Neurosci       Date:  2017-10-24       Impact factor: 5.639

Review 10.  Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.

Authors:  Justin Hou Ming Yung; Adria Giacca
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.